 | • レポートコード：MRC2312MG16487 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の多粒子ドラッグデリバリーシステム市場規模と予測を収録しています。・世界の多粒子ドラッグデリバリーシステム市場：売上、2018年-2023年、2024年-2029年 ・世界の多粒子ドラッグデリバリーシステム市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の多粒子ドラッグデリバリーシステム市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「顆粒」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 多粒子ドラッグデリバリーシステムのグローバル主要企業は、Elan drug Technologies、 Rochling Group、 Janssen、 Pfizer、 Novartis、 GlaxoSmithKline、 Sanofi、 Bayerなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、多粒子ドラッグデリバリーシステムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の多粒子ドラッグデリバリーシステム市場：タイプ別、2018年-2023年、2024年-2029年 世界の多粒子ドラッグデリバリーシステム市場：タイプ別市場シェア、2022年 ・顆粒、マイクロピル 世界の多粒子ドラッグデリバリーシステム市場：用途別、2018年-2023年、2024年-2029年 世界の多粒子ドラッグデリバリーシステム市場：用途別市場シェア、2022年 ・病院、クリニック、その他 世界の多粒子ドラッグデリバリーシステム市場：地域・国別、2018年-2023年、2024年-2029年 世界の多粒子ドラッグデリバリーシステム市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における多粒子ドラッグデリバリーシステムのグローバル売上、2018年-2023年 ・主要企業における多粒子ドラッグデリバリーシステムのグローバル売上シェア、2022年 ・主要企業における多粒子ドラッグデリバリーシステムのグローバル販売量、2018年-2023年 ・主要企業における多粒子ドラッグデリバリーシステムのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Elan drug Technologies、 Rochling Group、 Janssen、 Pfizer、 Novartis、 GlaxoSmithKline、 Sanofi、 Bayer ************************************************************* ・調査・分析レポートの概要 多粒子ドラッグデリバリーシステム市場の定義 市場セグメント 世界の多粒子ドラッグデリバリーシステム市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の多粒子ドラッグデリバリーシステム市場規模 世界の多粒子ドラッグデリバリーシステム市場規模：2022年 VS 2029年 世界の多粒子ドラッグデリバリーシステム市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの多粒子ドラッグデリバリーシステムの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の多粒子ドラッグデリバリーシステム製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：顆粒、マイクロピル 多粒子ドラッグデリバリーシステムのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、クリニック、その他 多粒子ドラッグデリバリーシステムの用途別グローバル売上・予測 ・地域別市場分析 地域別多粒子ドラッグデリバリーシステム市場規模 2022年と2029年 地域別多粒子ドラッグデリバリーシステム売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Elan drug Technologies、 Rochling Group、 Janssen、 Pfizer、 Novartis、 GlaxoSmithKline、 Sanofi、 Bayer ... |
This research report provides a comprehensive analysis of the Multiparticulate Drug Delivery System market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Multiparticulate Drug Delivery System market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Multiparticulate Drug Delivery System, challenges faced by the industry, and potential opportunities for market players.
The global Multiparticulate Drug Delivery System market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Multiparticulate Drug Delivery System market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Multiparticulate Drug Delivery System market. Additionally, the growing consumer demand present avenues for market expansion.
The global Multiparticulate Drug Delivery System market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Multiparticulate systems also face some challenges, such as production equipment limitations, long production steps, many influencing factors, and potential healing and stability issues. Take pellet tableting as an example. Due to the difficulty of the pellet tableting process, although the product can improve bioavailability, reduce drug dosage, and alleviate adverse reactions, it is easy to delaminate during the tableting process, and the coating film becomes compressed after being coated. It is easy to break, and the pellets collide and fuse with each other when pressed into tablets, and cannot quickly disintegrate into a single pellet in the gastrointestinal tract after taking it.
Key Features:
The research report on the Multiparticulate Drug Delivery System market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Multiparticulate Drug Delivery System market.
Market Overview: The report provides a comprehensive overview of the Multiparticulate Drug Delivery System market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Granules, Micropills), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Multiparticulate Drug Delivery System market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Multiparticulate Drug Delivery System market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Multiparticulate Drug Delivery System market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Multiparticulate Drug Delivery System market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Multiparticulate Drug Delivery System market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Multiparticulate Drug Delivery System market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Multiparticulate Drug Delivery System, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Multiparticulate Drug Delivery System market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Multiparticulate Drug Delivery System market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Granules
Micropills
Market segment by Application
Hospital
Clinic
Others
Global Multiparticulate Drug Delivery System Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Elan drug Technologies
Rochling Group
Janssen
Pfizer
Novartis
GlaxoSmithKline
Sanofi
Bayer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Multiparticulate Drug Delivery System, market overview.
Chapter 2: Global Multiparticulate Drug Delivery System market size in revenue and volume.
Chapter 3: Detailed analysis of Multiparticulate Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Multiparticulate Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Multiparticulate Drug Delivery System capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Multiparticulate Drug Delivery System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Multiparticulate Drug Delivery System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Multiparticulate Drug Delivery System Overall Market Size
2.1 Global Multiparticulate Drug Delivery System Market Size: 2022 VS 2029
2.2 Global Multiparticulate Drug Delivery System Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Multiparticulate Drug Delivery System Sales: 2018-2029
3 Company Landscape
3.1 Top Multiparticulate Drug Delivery System Players in Global Market
3.2 Top Global Multiparticulate Drug Delivery System Companies Ranked by Revenue
3.3 Global Multiparticulate Drug Delivery System Revenue by Companies
3.4 Global Multiparticulate Drug Delivery System Sales by Companies
3.5 Global Multiparticulate Drug Delivery System Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Multiparticulate Drug Delivery System Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Multiparticulate Drug Delivery System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Multiparticulate Drug Delivery System Players in Global Market
3.8.1 List of Global Tier 1 Multiparticulate Drug Delivery System Companies
3.8.2 List of Global Tier 2 and Tier 3 Multiparticulate Drug Delivery System Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Multiparticulate Drug Delivery System Market Size Markets, 2022 & 2029
4.1.2 Granules
4.1.3 Micropills
4.2 By Type – Global Multiparticulate Drug Delivery System Revenue & Forecasts
4.2.1 By Type – Global Multiparticulate Drug Delivery System Revenue, 2018-2023
4.2.2 By Type – Global Multiparticulate Drug Delivery System Revenue, 2024-2029
4.2.3 By Type – Global Multiparticulate Drug Delivery System Revenue Market Share, 2018-2029
4.3 By Type – Global Multiparticulate Drug Delivery System Sales & Forecasts
4.3.1 By Type – Global Multiparticulate Drug Delivery System Sales, 2018-2023
4.3.2 By Type – Global Multiparticulate Drug Delivery System Sales, 2024-2029
4.3.3 By Type – Global Multiparticulate Drug Delivery System Sales Market Share, 2018-2029
4.4 By Type – Global Multiparticulate Drug Delivery System Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Multiparticulate Drug Delivery System Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Multiparticulate Drug Delivery System Revenue & Forecasts
5.2.1 By Application – Global Multiparticulate Drug Delivery System Revenue, 2018-2023
5.2.2 By Application – Global Multiparticulate Drug Delivery System Revenue, 2024-2029
5.2.3 By Application – Global Multiparticulate Drug Delivery System Revenue Market Share, 2018-2029
5.3 By Application – Global Multiparticulate Drug Delivery System Sales & Forecasts
5.3.1 By Application – Global Multiparticulate Drug Delivery System Sales, 2018-2023
5.3.2 By Application – Global Multiparticulate Drug Delivery System Sales, 2024-2029
5.3.3 By Application – Global Multiparticulate Drug Delivery System Sales Market Share, 2018-2029
5.4 By Application – Global Multiparticulate Drug Delivery System Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Multiparticulate Drug Delivery System Market Size, 2022 & 2029
6.2 By Region – Global Multiparticulate Drug Delivery System Revenue & Forecasts
6.2.1 By Region – Global Multiparticulate Drug Delivery System Revenue, 2018-2023
6.2.2 By Region – Global Multiparticulate Drug Delivery System Revenue, 2024-2029
6.2.3 By Region – Global Multiparticulate Drug Delivery System Revenue Market Share, 2018-2029
6.3 By Region – Global Multiparticulate Drug Delivery System Sales & Forecasts
6.3.1 By Region – Global Multiparticulate Drug Delivery System Sales, 2018-2023
6.3.2 By Region – Global Multiparticulate Drug Delivery System Sales, 2024-2029
6.3.3 By Region – Global Multiparticulate Drug Delivery System Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Multiparticulate Drug Delivery System Revenue, 2018-2029
6.4.2 By Country – North America Multiparticulate Drug Delivery System Sales, 2018-2029
6.4.3 US Multiparticulate Drug Delivery System Market Size, 2018-2029
6.4.4 Canada Multiparticulate Drug Delivery System Market Size, 2018-2029
6.4.5 Mexico Multiparticulate Drug Delivery System Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Multiparticulate Drug Delivery System Revenue, 2018-2029
6.5.2 By Country – Europe Multiparticulate Drug Delivery System Sales, 2018-2029
6.5.3 Germany Multiparticulate Drug Delivery System Market Size, 2018-2029
6.5.4 France Multiparticulate Drug Delivery System Market Size, 2018-2029
6.5.5 U.K. Multiparticulate Drug Delivery System Market Size, 2018-2029
6.5.6 Italy Multiparticulate Drug Delivery System Market Size, 2018-2029
6.5.7 Russia Multiparticulate Drug Delivery System Market Size, 2018-2029
6.5.8 Nordic Countries Multiparticulate Drug Delivery System Market Size, 2018-2029
6.5.9 Benelux Multiparticulate Drug Delivery System Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Multiparticulate Drug Delivery System Revenue, 2018-2029
6.6.2 By Region – Asia Multiparticulate Drug Delivery System Sales, 2018-2029
6.6.3 China Multiparticulate Drug Delivery System Market Size, 2018-2029
6.6.4 Japan Multiparticulate Drug Delivery System Market Size, 2018-2029
6.6.5 South Korea Multiparticulate Drug Delivery System Market Size, 2018-2029
6.6.6 Southeast Asia Multiparticulate Drug Delivery System Market Size, 2018-2029
6.6.7 India Multiparticulate Drug Delivery System Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Multiparticulate Drug Delivery System Revenue, 2018-2029
6.7.2 By Country – South America Multiparticulate Drug Delivery System Sales, 2018-2029
6.7.3 Brazil Multiparticulate Drug Delivery System Market Size, 2018-2029
6.7.4 Argentina Multiparticulate Drug Delivery System Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Multiparticulate Drug Delivery System Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Multiparticulate Drug Delivery System Sales, 2018-2029
6.8.3 Turkey Multiparticulate Drug Delivery System Market Size, 2018-2029
6.8.4 Israel Multiparticulate Drug Delivery System Market Size, 2018-2029
6.8.5 Saudi Arabia Multiparticulate Drug Delivery System Market Size, 2018-2029
6.8.6 UAE Multiparticulate Drug Delivery System Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Elan drug Technologies
7.1.1 Elan drug Technologies Company Summary
7.1.2 Elan drug Technologies Business Overview
7.1.3 Elan drug Technologies Multiparticulate Drug Delivery System Major Product Offerings
7.1.4 Elan drug Technologies Multiparticulate Drug Delivery System Sales and Revenue in Global (2018-2023)
7.1.5 Elan drug Technologies Key News & Latest Developments
7.2 Rochling Group
7.2.1 Rochling Group Company Summary
7.2.2 Rochling Group Business Overview
7.2.3 Rochling Group Multiparticulate Drug Delivery System Major Product Offerings
7.2.4 Rochling Group Multiparticulate Drug Delivery System Sales and Revenue in Global (2018-2023)
7.2.5 Rochling Group Key News & Latest Developments
7.3 Janssen
7.3.1 Janssen Company Summary
7.3.2 Janssen Business Overview
7.3.3 Janssen Multiparticulate Drug Delivery System Major Product Offerings
7.3.4 Janssen Multiparticulate Drug Delivery System Sales and Revenue in Global (2018-2023)
7.3.5 Janssen Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Multiparticulate Drug Delivery System Major Product Offerings
7.4.4 Pfizer Multiparticulate Drug Delivery System Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Multiparticulate Drug Delivery System Major Product Offerings
7.5.4 Novartis Multiparticulate Drug Delivery System Sales and Revenue in Global (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Multiparticulate Drug Delivery System Major Product Offerings
7.6.4 GlaxoSmithKline Multiparticulate Drug Delivery System Sales and Revenue in Global (2018-2023)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Sanofi
7.7.1 Sanofi Company Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Multiparticulate Drug Delivery System Major Product Offerings
7.7.4 Sanofi Multiparticulate Drug Delivery System Sales and Revenue in Global (2018-2023)
7.7.5 Sanofi Key News & Latest Developments
7.8 Bayer
7.8.1 Bayer Company Summary
7.8.2 Bayer Business Overview
7.8.3 Bayer Multiparticulate Drug Delivery System Major Product Offerings
7.8.4 Bayer Multiparticulate Drug Delivery System Sales and Revenue in Global (2018-2023)
7.8.5 Bayer Key News & Latest Developments
8 Global Multiparticulate Drug Delivery System Production Capacity, Analysis
8.1 Global Multiparticulate Drug Delivery System Production Capacity, 2018-2029
8.2 Multiparticulate Drug Delivery System Production Capacity of Key Manufacturers in Global Market
8.3 Global Multiparticulate Drug Delivery System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Multiparticulate Drug Delivery System Supply Chain Analysis
10.1 Multiparticulate Drug Delivery System Industry Value Chain
10.2 Multiparticulate Drug Delivery System Upstream Market
10.3 Multiparticulate Drug Delivery System Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Multiparticulate Drug Delivery System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer